Trial Profile
A Pilot, Phase I, 2-Period, Fasting, Bioavailability, Safety and PK [pharmacokinetic] Study Evaluating A Single Dose Intravenous Fentanyl 200 microg) and Single Doses of 2 or 3 mL AeroLEF (Liposome-Encapsulated Fentanyl 500 microg/mL) in Normal Healthy Non-Smoking Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jul 2008
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary) ; Fentanyl (Primary)
- Indications Cancer pain; Postoperative pain
- Focus Adverse reactions
- Sponsors YM BioSciences
- 26 Jul 2008 New trial record.